These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 39363643)

  • 21. Leveraging process mining for modeling progression trajectories in amyotrophic lateral sclerosis.
    Tavazzi E; Gatta R; Vallati M; Cotti Piccinelli S; Filosto M; Padovani A; Castellano M; Di Camillo B
    BMC Med Inform Decis Mak; 2023 Feb; 22(Suppl 6):346. PubMed ID: 36732801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age at onset of amyotrophic lateral sclerosis in China.
    Liu MS; Cui LY; Fan DS;
    Acta Neurol Scand; 2014 Mar; 129(3):163-7. PubMed ID: 23819875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The changes of clinical characteristics in 100 Japanese amyotrophic lateral sclerosis patients between 1980 and 2000].
    Kimura F; Shinoda K; Fujiwara S; Fujimura C; Nakajima H; Furutama D; Sugino M; Hanafusa T
    Rinsho Shinkeigaku; 2003 Jul; 43(7):385-91. PubMed ID: 14582363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Brazilian multicentre study on the clinical and epidemiological profiles of 1116 patients with amyotrophic lateral sclerosis and its phenotypic variants.
    Marques Couto C; de Melo Queiroz E; Nogueira R; Pires Duarte Küsel AP; J M Nascimento O
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Aug; 23(5-6):353-362. PubMed ID: 34823435
    [No Abstract]   [Full Text] [Related]  

  • 25. Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1.
    Ahmeti KB; Ajroud-Driss S; Al-Chalabi A; Andersen PM; Armstrong J; Birve A; Blauw HM; Brown RH; Bruijn L; Chen W; Chio A; Comeau MC; Cronin S; Diekstra FP; Soraya Gkazi A; Glass JD; Grab JD; Groen EJ; Haines JL; Hardiman O; Heller S; Huang J; Hung WY; ; Jaworski JM; Jones A; Khan H; Landers JE; Langefeld CD; Leigh PN; Marion MC; McLaughlin RL; Meininger V; Melki J; Miller JW; Mora G; Pericak-Vance MA; Rampersaud E; Robberecht W; Russell LP; Salachas F; Saris CG; Shatunov A; Shaw CE; Siddique N; Siddique T; Smith BN; Sufit R; Topp S; Traynor BJ; Vance C; van Damme P; van den Berg LH; van Es MA; van Vught PW; Veldink JH; Yang Y; Zheng JG;
    Neurobiol Aging; 2013 Jan; 34(1):357.e7-19. PubMed ID: 22959728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic differences of amyotrophic lateral sclerosis (ALS) in China and Germany.
    Rosenbohm A; Liu M; Nagel G; Peter RS; Cui B; Li X; Kassubek J; Rothenbacher D; Lulé D; Cui L; Ludolph AC;
    J Neurol; 2018 Apr; 265(4):774-782. PubMed ID: 29392461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutrophils-to-Lymphocyte Ratio Is Associated with Progression and Overall Survival in Amyotrophic Lateral Sclerosis.
    Leone MA; Mandrioli J; Russo S; Cucovici A; Gianferrari G; Lisnic V; Muresanu DF; Giuliani F; Copetti M; The Pooled Resource Open-Access Als Clinical Trials Consortium ; Fontana A
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016.
    Mehta P; Raymond J; Punjani R; Larson T; Bove F; Kaye W; Nelson LM; Topol B; Han M; Muravov O; Genson C; Davis B; Hicks T; Horton K
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 May; 23(3-4):220-225. PubMed ID: 34423697
    [No Abstract]   [Full Text] [Related]  

  • 29. Reproductive History and Age of Onset for Women Diagnosed with Amyotrophic Lateral Sclerosis: Data from the National ALS Registry: 2010-2018.
    Raymond J; Mehta P; Larson T; Pioro EP; Horton DK
    Neuroepidemiology; 2021; 55(5):416-424. PubMed ID: 34218222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Incidence of Amyotrophic Lateral Sclerosis in Ohio 2016-2018: The Ohio Population-Based ALS Registry.
    Andrew AS; Pioro EP; Li M; Shi X; Gui J; Stommel EW; Butt TH; Peipert D; Henegan P; Tischbein M; Cazzolli P; Novak J; Quick A; Pugar KD; Sawlani K; Katirji B; Hayes TA; Horton DK; Mehta P; Bradley WG
    Neuroepidemiology; 2021; 55(3):196-205. PubMed ID: 33902051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: An update of LIGALS register.
    Scialò C; Novi G; Bandettini di Poggio M; Canosa A; Sormani MP; Mandich P; Origone P; Truffelli R; Mancardi GL; Caponnetto C
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(7-8):535-542. PubMed ID: 27399231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and epidemiological characteristics of amyotrophic lateral sclerosis in an Egyptian cohort.
    Soliman R; Onbool E; Omran K; Fahmy N
    Neurol Sci; 2024 Sep; ():. PubMed ID: 39349916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Classifying Patients with Amyotrophic Lateral Sclerosis by Changes in FVC. A Group-based Trajectory Analysis.
    Ackrivo J; Hansen-Flaschen J; Jones BL; Wileyto EP; Schwab RJ; Elman L; Kawut SM
    Am J Respir Crit Care Med; 2019 Dec; 200(12):1513-1521. PubMed ID: 31322417
    [No Abstract]   [Full Text] [Related]  

  • 34. Age-period-cohort analysis of trends in amyotrophic lateral sclerosis incidence.
    Tobin K; Gilthorpe MS; Rooney J; Heverin M; Vajda A; Staines A; Hardiman O
    J Neurol; 2016 Oct; 263(10):1919-26. PubMed ID: 27372451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?
    Czaplinski A; Yen AA; Simpson EP; Appel SH
    Arch Neurol; 2006 Aug; 63(8):1139-43. PubMed ID: 16908741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of aneurysmal subarachnoid hemorrhage as a multistep process.
    Ruigrok YM; Rinkel GJE; Chang HS; Hackenberg KAM; Etminan N; Veldink JH
    Eur J Neurol; 2024 Feb; 31(2):e16118. PubMed ID: 37877684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort.
    Talman P; Duong T; Vucic S; Mathers S; Venkatesh S; Henderson R; Rowe D; Schultz D; Edis R; Needham M; Macdonnell R; McCombe P; Birks C; Kiernan M
    BMJ Open; 2016 Sep; 6(9):e012054. PubMed ID: 27694488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A spatial analysis of amyotrophic lateral sclerosis (ALS) cases in the United States and their proximity to multidisciplinary ALS clinics, 2013.
    Horton DK; Graham S; Punjani R; Wilt G; Kaye W; Maginnis K; Webb L; Richman J; Bedlack R; Tessaro E; Mehta P
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):126-133. PubMed ID: 29262737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demographics, clinical characteristics, and prognostic factors of amyotrophic lateral sclerosis in Midwest.
    Yamakawa M; Dwyer S; Song X; Statland J
    Muscle Nerve; 2022 Feb; 65(2):217-224. PubMed ID: 34708421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A retrospective study of the clinical phenotype and predictors of survival in non-Caucasian Hispanic patients with amyotrophic lateral sclerosis.
    Sánchez-Martínez CM; Choreño-Parra JA; Nuñez-Orozco L; Placencia-Álvarez N; Alvis-Castaño LM; Guadarrama-Ortiz P
    BMC Neurol; 2019 Oct; 19(1):261. PubMed ID: 31664949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.